Publications

2022

Burnham P, Chen F, Cheng AP, Srivatana V, Zhang LT, Edusei E, et al. Peritoneal Effluent Cell-Free DNA Sequencing in Peritoneal Dialysis Patients With and Without Peritonitis. Kidney Med. 2022;4(1):100383.
van der Mijn JC, Chen Q, Laursen KB, Khani F, Wang X, Dorsaint P, et al. Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR). Mol Carcinog. 2022;61(9):851-864.
Panarelli NC. In Reply. Arch Pathol Lab Med. 2022;146(10):1182a-1182.
Cai PY, Asad M, Augello MA, Martin L, Louie C, Basourakos SP, et al. A multidisciplinary approach to optimize primary prostate cancer biobanking. Urol Oncol. 2022;40(6):271.e1-271.e7.
Cayrol F, Revuelta MV, Debernardi M, Paulazo A, Phillip JM, Zamponi N, et al. Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma. Mol Cancer Ther. 2022;21(9):1485-1496.
Francini E, Fanelli GN, Pederzoli F, Spisak S, Minonne E, Raffo M, et al. Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine. Cancers (Basel). 2022;14(18).
Koeller DR, Schwartz A, DeSimone MS, Rana HQ, Rojas-Rudilla V, Russell-Goldman E, et al. Vulvar Melanoma in association with germline MITF p.E318K variant. Cancer Genet. 2022;262-263:102-106.
Vlachostergios PJ, Niaz MJ, Thomas C, Christos PJ, Osborne JR, Margolis DJ, et al. Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer. Prostate. 2022;82(4):483-492.
Thomas-Wilson A, Dharmadhikari AV, Heymann JJ, Jobanputra V, DiMauro S, Hirano M, et al. Whole-exome sequencing detects PYGM variants in two adults with McArdle disease. Cold Spring Harb Mol Case Stud. 2022;8(2).

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700